SCHEMBL6223286

SCHEMBL6223286

OCCCCc1c2ccccc2nc2ccccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.58
GAA P10253 3/20 0.58
ALDH1A1 P00352 3/20 0.58
HPGD P15428 2/20 0.58
POLB P06746 3/20 0.54
RAD52 P43351 2/20 0.54
GLA P06280 3/20 0.49
RAB9A P51151 2/20 0.49
MITF O75030 1/20 0.49
LMNA P02545 1/20 0.49
TTR P02766 1/20 0.49
TSHR P16473 1/20 0.46
MAPT P10636 1/20 0.46
TLR8 Q9NR97 4/20 0.45
PDE5A O76074 1/20 0.44
JAK2 O60674 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
MAOA P21397 2/20 0.42
CHRM2 P08172 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL320907 0.90 KDM4E (0.69) KDM4EGAAALDH1A1HPGDPOLB
SCHEMBL29446754 0.90 KDM4E (0.69) KDM4EGAAALDH1A1HPGDPOLB
SCHEMBL601351 0.88 KDM4E (0.67) KDM4EGAAALDH1A1HPGDPOLB
SCHEMBL320922 0.88 KDM4E (0.67) KDM4EGAAALDH1A1HPGDPOLB
SCHEMBL321157 0.88 KDM4E (0.67) KDM4EGAAALDH1A1HPGDPOLB
SCHEMBL194341 0.88 KDM4E (0.67) KDM4EGAAALDH1A1HPGDPOLB
SCHEMBL600275 0.88 KDM4E (0.67) KDM4EGAAALDH1A1HPGDPOLB
SCHEMBL599897 0.88 KDM4E (0.67) KDM4EGAAALDH1A1HPGDPOLB
SCHEMBL194585 0.88 KDM4E (0.67) KDM4EGAAALDH1A1HPGDPOLB
SCHEMBL321523 0.88 KDM4E (0.67) KDM4EGAAALDH1A1HPGDPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1142902-B1 3'-derivatised oligonucleotide analogues with non-nucleotidic groups, their preparation and use AVENTIS PHARMA GMBH (DE) 2005-10-26 EP disclosed
EP-0552766-B1 Oligonucleotide analogues, their preparation and use AVENTIS PHARMA GMBH (DE) 2002-05-22 EP disclosed
EP-1142902-A2 3'-Derivatised oligonucleotide analogues with non-nucleotidic groups, their preparation and use HOECHST AKTIENGESELLSCHAFT (DE) 2001-10-10 EP disclosed
US-6033909-A INHIBITORS OF GENE EXPRESSION HOECHST AKTIENGESELLSCHAFT (DE) 2000-03-07 US disclosed
US-5646261-A PHOSPHORUS DERIVATIZED; ANTISENSE AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 1997-07-08 US disclosed
EP-0552766-A2 Oligonucleotide analogues, their preparation and use HOECHST AKTIENGESELLSCHAFT (DE) 1993-07-28 EP disclosed
EP-0552767-A2 3'-derivatised oligonucleotide analogues with non-nucleotidic groups, their preparation and use HOECHST AKTIENGESELLSCHAFT (DE) 1993-07-28 EP disclosed